成立于1997年,較早布局中醫藥全產業,以中藥飲片為核心,以智慧藥房為抓手,打造大健康+大平臺+大數據+大服務體系
康(kang)美(mei)藥業(ye)股份有限公司(si)(600518)成立(li)于(yu)1997年,于(yu)2001年在(zai)上交(jiao)所上市。公司(si)秉承“心懷蒼生、大(da)愛(ai)(ai)無疆(jiang)”的核(he)心價值觀和“用愛(ai)(ai)感動世(shi)界(jie)、用心經營(ying)(ying)健康(kang)”的經營(ying)(ying)理(li)念,在(zai)國家(jia)振興中(zhong)(zhong)醫藥事業(ye)戰略指引(yin)下(xia),布局中(zhong)(zhong)醫藥全產業(ye)鏈(lian),以中(zhong)(zhong)藥飲(yin)片為(wei)核(he)心,以智慧(hui)藥房為(wei)抓手,打造(zao)“大(da)健康(kang)+大(da)平臺+大(da)數據(ju)+大(da)服(fu)務(wu)”體系(xi),成為(wei)中(zhong)(zhong)醫藥全產業(ye)鏈(lian)精準(zhun)服(fu)務(wu)型“智慧(hui)+”大(da)健康(kang)產業(ye)上市企業(ye)、國家(jia)高新技術企業(ye)。
康美藥(yao)(yao)(yao)(yao)(yao)(yao)業(ye)(ye)(ye)上(shang)(shang)(shang)至藥(yao)(yao)(yao)(yao)(yao)(yao)材(cai)(cai)種(zhong)植、藥(yao)(yao)(yao)(yao)(yao)(yao)材(cai)(cai)交(jiao)易(yi),下至生(sheng)產(chan)(chan)(chan)開發(fa)(fa)、終(zhong)端銷(xiao)售,已基(ji)本(ben)貫穿中(zhong)(zhong)(zhong)(zhong)醫(yi)藥(yao)(yao)(yao)(yao)(yao)(yao)產(chan)(chan)(chan)業(ye)(ye)(ye)鏈(lian)的(de)(de)上(shang)(shang)(shang)、中(zhong)(zhong)(zhong)(zhong)、下游產(chan)(chan)(chan)業(ye)(ye)(ye),業(ye)(ye)(ye)務滲透中(zhong)(zhong)(zhong)(zhong)醫(yi)藥(yao)(yao)(yao)(yao)(yao)(yao)全(quan)產(chan)(chan)(chan)業(ye)(ye)(ye)鏈(lian)的(de)(de)各(ge)個關鍵環節,有效地整合(he)全(quan)產(chan)(chan)(chan)業(ye)(ye)(ye)鏈(lian)資源。公司先后在全(quan)國(guo)(guo)(guo)(guo)(guo)各(ge)地投(tou)資建立140多家(jia)(jia)(jia)(jia)涵蓋藥(yao)(yao)(yao)(yao)(yao)(yao)材(cai)(cai)種(zhong)植、中(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)材(cai)(cai)交(jiao)易(yi)市(shi)場、現(xian)代物(wu)流(liu)中(zhong)(zhong)(zhong)(zhong)心(xin)和產(chan)(chan)(chan)業(ye)(ye)(ye)基(ji)地等(deng)(deng)業(ye)(ye)(ye)務的(de)(de)企(qi)業(ye)(ye)(ye),管(guan)理的(de)(de)交(jiao)易(yi)市(shi)場交(jiao)易(yi)規(gui)模(mo)占全(quan)國(guo)(guo)(guo)(guo)(guo)的(de)(de)60%以上(shang)(shang)(shang),做出了(le)多個方面的(de)(de)國(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)標(biao)準(zhun)(zhun)(zhun):制定中(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)飲片國(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)標(biao)準(zhun)(zhun)(zhun)以及生(sheng)產(chan)(chan)(chan)管(guan)理GMP、小(xiao)包(bao)裝、色標(biao)管(guan)理、炮制等(deng)(deng)國(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)標(biao)準(zhun)(zhun)(zhun)。參與國(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)商務部(bu)中(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)材(cai)(cai)等(deng)(deng)級(ji)(ji)分類(lei)標(biao)準(zhun)(zhun)(zhun)制訂(ding)。承擔編(bian)制和運營國(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)發(fa)(fa)改委(wei)批(pi)準(zhun)(zhun)(zhun)、授(shou)權(quan)發(fa)(fa)布的(de)(de)全(quan)國(guo)(guo)(guo)(guo)(guo)中(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)材(cai)(cai)價格(ge)指數——康美·中(zhong)(zhong)(zhong)(zhong)國(guo)(guo)(guo)(guo)(guo)中(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)材(cai)(cai)價格(ge)指數。推(tui)出“實體與虛(xu)擬市(shi)場相結合(he)”的(de)(de)中(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)材(cai)(cai)大(da)宗(zong)現(xian)貨(huo)交(jiao)易(yi)平臺(tai)(tai)(tai),開創(chuang)中(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)材(cai)(cai)交(jiao)易(yi)新模(mo)式。承擔編(bian)制700多項(xiang)中(zhong)(zhong)(zhong)(zhong)醫(yi)藥(yao)(yao)(yao)(yao)(yao)(yao)編(bian)碼的(de)(de)國(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)標(biao)準(zhun)(zhun)(zhun),助力實施(shi)統一的(de)(de)中(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)、中(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)方劑、中(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)供應鏈(lian)編(bian)碼體系、成為(wei)國(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)信息化(hua)醫(yi)療機構服務平臺(tai)(tai)(tai)試(shi)點單位,康美智慧(hui)藥(yao)(yao)(yao)(yao)(yao)(yao)房(fang)被(bei)列為(wei)國(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)中(zhong)(zhong)(zhong)(zhong)醫(yi)藥(yao)(yao)(yao)(yao)(yao)(yao)服務標(biao)準(zhun)(zhun)(zhun)化(hua)研(yan)究(jiu)基(ji)地,打造(zao)了(le)互聯網(wang)時(shi)代的(de)(de)就醫(yi)用藥(yao)(yao)(yao)(yao)(yao)(yao)新模(mo)式。是承擔藥(yao)(yao)(yao)(yao)(yao)(yao)典會動物(wu)藥(yao)(yao)(yao)(yao)(yao)(yao)中(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)飲片炮制規(gui)范(fan)項(xiang)目(mu)(mu)企(qi)業(ye)(ye)(ye),獲(huo)批(pi)國(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)民營網(wang)絡醫(yi)院(yuan)(yuan)資質。組(zu)(zu)建了(le)由(you)6位中(zhong)(zhong)(zhong)(zhong)科院(yuan)(yuan)、工程院(yuan)(yuan)院(yuan)(yuan)士及眾多國(guo)(guo)(guo)(guo)(guo)醫(yi)大(da)師組(zu)(zu)成的(de)(de)專(zhuan)家(jia)(jia)(jia)(jia)委(wei)員會,在廣州和北京(jing)設立康美藥(yao)(yao)(yao)(yao)(yao)(yao)物(wu)研(yan)究(jiu)院(yuan)(yuan),擁(yong)有“國(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)企(qi)業(ye)(ye)(ye)技(ji)術中(zhong)(zhong)(zhong)(zhong)心(xin)”等(deng)(deng)20多個國(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)及省(sheng)部(bu)級(ji)(ji)研(yan)發(fa)(fa)平臺(tai)(tai)(tai)和14個自主(zhu)研(yan)發(fa)(fa)平臺(tai)(tai)(tai),已開展中(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)國(guo)(guo)(guo)(guo)(guo)際化(hua)、中(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)標(biao)準(zhun)(zhun)(zhun)化(hua)等(deng)(deng)國(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)及省(sheng)部(bu)級(ji)(ji)重大(da)項(xiang)目(mu)(mu)近百個,主(zhu)持(chi)和參加制定國(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)、行業(ye)(ye)(ye)標(biao)準(zhun)(zhun)(zhun)數十項(xiang),獲(huo)批(pi)國(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)或國(guo)(guo)(guo)(guo)(guo)際組(zu)(zu)織(zhi)認證的(de)(de)實驗(yan)室3個,獲(huo)得省(sheng)級(ji)(ji)及以上(shang)(shang)(shang)科技(ji)獎勵15項(xiang)。擁(yong)有發(fa)(fa)明專(zhuan)利、實用新型專(zhuan)利、外觀設計專(zhuan)利、軟件著(zhu)作權(quan)等(deng)(deng)知識產(chan)(chan)(chan)權(quan)達620余(yu)項(xiang),是國(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)技(ji)術創(chuang)新示范(fan)企(qi)業(ye)(ye)(ye)和國(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)智能制造(zao)試(shi)點示范(fan)企(qi)業(ye)(ye)(ye)、國(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)知識產(chan)(chan)(chan)權(quan)優勢(shi)企(qi)業(ye)(ye)(ye)。
公(gong)司在(zai)全國建(jian)立(li)了(le)17個(ge)中(zhong)(zhong)(zhong)藥飲片和醫(yi)(yi)藥現(xian)代化生產(chan)基地(di),與(yu)超過2000家(jia)醫(yi)(yi)療機構、20萬家(jia)藥店建(jian)立(li)了(le)合(he)作關系,年(nian)門診總(zong)量達到2.5億人(ren)次以上,投資管理康(kang)美醫(yi)(yi)院(yuan)、康(kang)美梅河口(kou)中(zhong)(zhong)(zhong)心醫(yi)(yi)院(yuan)、康(kang)美開原(yuan)市中(zhong)(zhong)(zhong)心醫(yi)(yi)院(yuan)、康(kang)美通城人(ren)民醫(yi)(yi)院(yuan)、康(kang)美柳河中(zhong)(zhong)(zhong)心醫(yi)(yi)院(yuan)等多家(jia)公(gong)立(li)醫(yi)(yi)院(yuan),在(zai)100多家(jia)公(gong)立(li)醫(yi)(yi)院(yuan)開展醫(yi)(yi)藥物流(liu)延伸配(pei)送(song)服務。
公(gong)司以(yi)國家(jia)(jia)中(zhong)醫(yi)藥(yao)(yao)管理(li)局(ju)(ju)信(xin)息化醫(yi)療服(fu)務平臺試點(dian)單位為契機,在(zai)中(zhong)醫(yi)藥(yao)(yao)行(xing)業把互(hu)聯(lian)網深(shen)度布(bu)局(ju)(ju)全(quan)產(chan)業鏈(lian)中(zhong),以(yi)中(zhong)藥(yao)(yao)飲(yin)片為核心,以(yi)智(zhi)慧藥(yao)(yao)房(fang)為抓手,圍繞(rao)“大(da)(da)健(jian)康+大(da)(da)平臺+大(da)(da)數(shu)據+大(da)(da)服(fu)務”體系,以(yi)全(quan)產(chan)業鏈(lian)資源(yuan)優勢(shi),積極(ji)探索中(zhong)醫(yi)藥(yao)(yao)工業智(zhi)能制造(zao)4.0,打造(zao)“智(zhi)慧藥(yao)(yao)房(fang)”模(mo)式,國務院辦公(gong)廳、國家(jia)(jia)衛健(jian)委、國家(jia)(jia)中(zhong)醫(yi)藥(yao)(yao)管理(li)局(ju)(ju)先(xian)后發文,明確(que)“鼓(gu)勵有條件(jian)的醫(yi)療機構(gou)推進‘智(zhi)慧藥(yao)(yao)房(fang)’建(jian)設,實(shi)現處方(fang)(fang)系統(tong)與藥(yao)(yao)房(fang)配方(fang)(fang)系統(tong)無縫對接。”“智(zhi)慧藥(yao)(yao)房(fang)”模(mo)式上升為行(xing)業標準,為患者提供了“一站式”藥(yao)(yao)事服(fu)務,實(shi)現了“讓信(xin)息多跑路,讓群(qun)眾少跑腿”。
康美藥(yao)業(ye)(ye)將以(yi)“經營(ying)有界(jie)、突出主業(ye)(ye)”為(wei)指導思想,圍(wei)繞“聚焦(jiao)核心(xin)業(ye)(ye)務、提高(gao)核心(xin)競爭力”的工作方(fang)針,明確以(yi)中(zhong)藥(yao)飲片及(ji)其制品為(wei)核心(xin)業(ye)(ye)務,通過有機(ji)整(zheng)合公(gong)司的產(chan)業(ye)(ye)布局優(you)勢、線(xian)上線(xian)下互相強化的采(cai)購優(you)勢、研(yan)發制成與質管(guan)優(you)勢、營(ying)銷服務優(you)勢,成為(wei)具備中(zhong)醫藥(yao)全產(chan)業(ye)(ye)鏈動(dong)態(tai)整(zheng)合和規范經營(ying)能(neng)力的標桿企業(ye)(ye)。